Skip to content

Blueberry Intake and Infant Gut Health

Blueberry Intake and Infant Gut Health

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05006989
Enrollment
75
Registered
2021-08-16
Start date
2021-09-01
Completion date
2025-03-30
Last updated
2025-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant Development

Keywords

Blueberries, Gut microbiota, Inflammation, Innate immunity, Early complementary feeding

Brief summary

The objective of this project is to investigate the effects of blueberries on gut microbiota, inflammation and innate immunity in breastfed infants during early complementary feeding (\ 5 to 12 months of age).

Detailed description

Some details are intentionally left to out to preserve the scientific integrity of the study, and they will be included in the record after the study is completed.

Interventions

Administered one packet per day (10 grams/packet) and participants consume up to 10 grams per day.

OTHERPlacebo Powder

Administered one packet per day (10 grams/packet) and participants consume up to 10 grams per day.

Sponsors

U.S. Highbush Blueberry Council
CollaboratorOTHER
University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
4 Months to 5 Months
Healthy volunteers
Yes

Inclusion criteria

* Generally healthy * Full term (gestational age ≥ 37 weeks) * No prior exposure of solid foods * Exclusively breastfed (\< 2 weeks of cumulative formula exposure) * Willing to consume blueberry/placebo powder

Exclusion criteria

* Having health conditions that would affect normal growth * Pre-term * Consumed formula for more than two weeks * Not willing to consume the blueberry/placebo powders

Design outcomes

Primary

MeasureTime frameDescription
Gut Microbiome Composition Analyzed using 16S rRNA Amplicon SequencingOver 7 months16S rRNA amplicon sequencing is used to profile taxonomic makeup of fecal specimens. Within the gut microbiome composition, microbial diversity will be summarized using common ecological measures (Good's coverage, Sobs, and Shannon alpha diversity).
Infant Growth (Length)Over 7 monthsMeasured in cm
Infant Growth (Weight)Over 7 monthsMeasured in kg
Dietary IntakeOver 7 months3 day dietary recall with results generated by NDSR software

Secondary

MeasureTime frameDescription
Blueberry-Specific Food Signatures (Compounds) as Assessed by Metabolomics AnalysisOver 7 monthsMetabolomics analysis (nutri-metabolomics) is used to identify and validate food-derived biomarkers that may be classified as biomarkers of intake and/or biomarkers of effect, both of which can be linked to health indicators.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026